Halozyme Therapeutics Inc

Halozyme Therapeutics Inc., founded in 1998, operates its headquarters in San Diego, California, in the United States. Positioned predominantly in the biopharmaceutical sector, Halozyme is engaged in developing and marketing products that interact with the extracellular matrix. These products have applications across drug delivery, oncology, and dermatology. The company's flagship offering is the ENHANZE® drug delivery technology, which enhances the absorption and dispersion of injectable drugs. By doing so, it aims to minimize the frequency of injections required for certain treatments. With a global reach, Halozyme Therapeutics markets its products and services both in the United States and internationally, leveraging partnerships and collaborations to expand its presence in various markets. (Powered by AI)